Boehringer Ingelheim | Company Profile
Contact Information
Industry & Market
Company Metrics
Funding Information
Headcount Distribution
By Department
Department Breakdown
Technology Stack
Email & Communication
Keywords & Focus Areas
Boehringer Ingelheim
Overview
Boehringer Ingelheim is a global, family-owned pharmaceutical company founded in 1885 in Ingelheim am Rhein, Germany. With around 53,000 employees in over 130 countries, it has evolved from a small chemical factory into one of the leading pharmaceutical enterprises worldwide.
The company develops innovative drug therapies for both human and animal health. Its human pharmaceutical portfolio includes treatments for cardiovascular health, oncology, respiratory diseases, metabolic disorders, immunology, and retinal health, featuring notable drugs like Spiriva, Pradaxa, and Jardiance. In animal health, Boehringer Ingelheim creates vaccines and pharmaceuticals to prevent and treat diseases in livestock and pets, supporting veterinarians and animal owners globally. The company is dedicated to scientific innovation and invests significantly in research and development to address emerging health challenges.
Basic Information
| Industry | pharmaceuticals |
|---|---|
| Founded | 1885 |
| Revenue | 27.9B |
| Headquarters | 173 Binger Strasse, Ingelheim am Rhein, Rhineland-Palatinate, Germany, 55218 |
| Languages | English, German, Spanish, French, Italian, Portuguese, Chinese, Japanese, Russian |
| Alexa Ranking | 130489 |
Contact Details
- Phone: +49 6132 770
- Website: boehringer-ingelheim.com
- LinkedIn: linkedin.com/company/boehringer-ingelheim
Key Focus Areas & Initiatives
- pharmaceuticals
- animal health
- innovation
- research
- health care
- improve health
- biopharmaceuticals
- contract manufacturing
- biotechnology
- life sciences
- pharmaceutical manufacturing
- respiratory drugs
- pharmaceutical and medicine manufacturing
- biotech r&d support
- veterinary vaccines
- animal health vaccines
- biopharma manufacturing
- biotech manufacturing
- stroke prevention medication
- pulmonary fibrosis treatments
- biotech research collaborations
- innovative treatments
- biotech support
- drug development
- biotech innovation
- lung cancer treatments
- oncology
- biotech collaboration
- copd treatments
- environmental responsibility
- cardiovascular drugs
- animal vaccines
- b2b
- animal disease treatments
- long-term perspective
- biopharma supply chain
- medical research
- global presence
- disease management
- veterinary pharmaceuticals
- research and development
- veterinary medicines
- biotech process development
- long-term pharma strategy
- metabolic disease treatments
- biopharma contract manufacturing
- neurological treatments
- pharmaceutical
- healthcare sustainability
- biopharmaceutical support services
- animal health innovation
- healthcare access
- sustainable pharmaceutical practices
- digital health
- global healthcare
- respiratory treatments
- healthcare
- global biotech partnerships
- family-owned business
- sustainability
- family-owned pharma
- oncology drugs
- patient outcomes
- therapeutic solutions
- biopharma pipeline
- services
- healthcare innovation
- biopharmaceutical
- manufacturing
- medical
- health, wellness & fitness
- mechanical or industrial engineering
- hospital & health care
- research & development
- information technology & services
- environmental services
- renewables & environment
Technologies Used
- Drupal
- Microsoft Office 365
- Outlook
- Remote
- VueJS
Community
